Dataset from the randomized controlled trial of CD38-targeted therapy in ITP
收藏官方服务:
资源简介:
This dataset originates from the first randomized, double-blind, placebo-controlled clinical trial conducted in China to evaluate the safety, efficacy, and immunological changes associated with CD38 monoclonal antibody therapy in adults with primary immune thrombocytopenia (ITP).
创建时间:
2025-07-09



